Evidence map›Paper›PMID 28470346›Full record

ReviewIntensive care medicine2017

The ICM research agenda on extracorporeal life support.

Alain Combes, Dan Brodie, Yih-Sharng Chen, Eddy Fan, José P S Henriques, Carol Hodgson, Philipp M Lepper, Pascal Leprince, Kunihiko Maekawa, Thomas Muller and 8 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Intensive care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Impact of extracorporeal circuits on systemic drug levels - a scoping review.Journal of anesthesia, analgesia and critical care · 2026
    Review
  5. Full percutaneous decannulation of VA-ECMO using MANTACritical care (London, England) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Redefining weaning in a VA ECMO: a case report on pump-controlled retrograde trial off.Indian journal of thoracic and cardiovascular surgery · 2025
    Article
  11. Article
  12. ECMO for bridging lung transplantation.European journal of medical research · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alain CombesMedical-Surgical Intensive Care Unit, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, F-75013, Paris, France. alain.combes@aphp.fr.
Dan BrodieDivision of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center/New York-Presbyterian Hospital, Columbia University, New York, NY, USA.
Yih-Sharng ChenCardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Eddy FanInterdepartmental Division of Critical Care Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
José P S HenriquesAMC Heart Center, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands.
Carol HodgsonANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University and Physiotherapy Department, The Alfred, Melbourne, Australia.
Philipp M LepperDepartment of Internal Medicine V-Pneumology and Critical Care Medicine, ECLS Centre Saar, University Hospital of Saarland, Homburg, Germany.
Pascal LeprinceInstitute of Cardiometabolism and Nutrition, Sorbonne University, UPMC Univ Paris 06, INSERM, UMRS_1166-ICAN, F-75013, Paris, France.
Kunihiko MaekawaEmergency and Critical Care Center, Hokkaido University Hospital, Sapporo, Japan.
Thomas MullerDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Sebastian NudingDepartment of Medicine III, University Hospital Halle (Saale) of the Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Dagmar M OuweneelAMC Heart Center, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands.
Antoine RochRéanimation des Détresses Respiratoires et Infections Sévères, CHU Nord, UMR CNRS 7278, Aix-Marseille Université, Marseille, France.
Matthieu SchmidtMedical-Surgical Intensive Care Unit, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, F-75013, Paris, France.
Hiroo TakayamaDepartment of Surgery, Division of Cardiothoracic and Vascular Surgery, Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Alain VuylstekePapworth Hospital NHS Foundation Trust, Papworth, UK.
Karl WerdanDepartment of Medicine III, University Hospital Halle (Saale) of the Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Laurent PapazianRéanimation des Détresses Respiratoires et Infections Sévères, CHU Nord, UMR CNRS 7278, Aix-Marseille Université, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to concisely describe the current standards of care, major recent advances, common beliefs that have been contradicted by recent trials, areas of uncertainty, and clinical studies that need to be performed over the next decade and their expected outcomes with regard to extracorporeal membrane oxygenation (ECMO).

methodsNarrative review based on a systematic analysis of the medical literature, national and international guidelines, and expert opinion.

resultsThe use of venovenous ECMO (VV-ECMO) is increasing in the most severe forms of acute lung injury. In patients with cardiogenic shock, short-term veno-arterial ECMO (VA-ECMO) provides both pulmonary and circulatory support. Technological improvements and recently published studies suggest that ECMO is able to improve patients' outcomes. There are, however, many uncertainties regarding the real benefits of this technique both in hemodynamic and respiratory failure, the territorial organization to deliver ECMO, the indications and the use of concomitant treatments.

conclusionsAlthough there have been considerable advances regarding the use of ECMO in critically ill patients, the risk/benefit ratio remains underinvestigated. ECMO indications, organization of ECMO delivery, and use of adjuvant therapeutics need also to be explored. Ongoing and future studies may be able to resolve these issues.

Indexed as

Outcome Assessment, Health CareAcute Lung InjuryBiomedical ResearchCritical IllnessExtracorporeal Membrane OxygenationHeart ArrestHumansPractice Guidelines as TopicProspective StudiesRandomized Controlled Trials as TopicRespiration, ArtificialRespiratory InsufficiencyRetrospective StudiesShock, CardiogenicAcute respiratory distress syndromeCardiogenic shockExtracorporeal membrane oxygenationPosition articleResearch agenda

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.